secwatch.observer — SEC 8-K summary
======================================

Issuer:     CALLAN JMB INC. (CJMB)
CIK:        0002032545
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001641172-25-024067
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Callan JMB Q2 revenue $1.7M, operating loss $1.4M; forms Revival partnership, secures $25M equity line
--------------------------------------------------------------------------------

- Q2 2025 revenue $1.7M, down YoY; H1 revenue $3.1M; gross profit $0.6M and $1.3M respectively.
- Operating loss of $1.4M (Q2) and $2.6M (H1); SG&A rose to $2.0M in Q2 on public-company and hiring costs.
- Cash $4.2M at June 30; post-quarter equity line for up to $25M of common stock.
- Strategic partnership with Revival Health; launched Indian subsidiary with temperature-controlled warehouse.
- Extended Chicago emergency contract to June 2026 with $1.5M increase, total $9.1M; appointed Christopher Shields as SVP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2032545/000164117225024067/0001641172-25-024067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2032545/000164117225024067/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-024067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer